Arbutus Biopharma Corporation
News
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
Zacks Investment Research Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. HCA Healthcare (HCA) is a stock that can certainly grab the attention of many...\n more…
Arbutus Biopharma (NASDAQ:ABUS) PT Raised to $7.00
Ticker Report Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) had its price target increased by analysts at Jefferies Financial Group from $5.00 to $7.00 in a report released on Thursday, Benzinga reports. The...\n more…
Arbutus to Participate in Two Upcoming Investor Conferences
Globe Newswire WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) ( Arbutus or the Company ), a clinical-stage biopharmaceutical company leveraging its extensive...\n more…
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Arbutus Biopharma (ABUS) is a stock that can certainly grab the...\n more…
California State Teachers Retirement System Lowers Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS)
Ticker Report California State Teachers Retirement System trimmed its stake in Arbutus Biopharma Co. (NASDAQ:ABUS - Free Report) by 38.9% during the first quarter, according to its most recent 13F filing with the...\n more…
Price T Rowe Associates Inc. MD Acquires 6,649 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)
Zolmax Price T Rowe Associates Inc. MD grew its stake in shares of Arbutus Biopharma Co. (NASDAQ:ABUS - Free Report) by 22.4% during the first quarter, Holdings Channel reports. The institutional investor...\n more…